Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Wenguang, Gu"'
Autor:
Xing Lei, Kewei Wang, Wenbo Wang, Hao Jin, Wenguang Gu, Zhiguo Chen, Wei Wang, Kaituo Gao, Huan Wang
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background Osteosarcoma (OS) is a common malignant bone tumor with poor prognosis. We previously reviewed that CD146 is correlated with multiple cancer progression, while its impact on OS is currently not systematically studied. Methods MG63
Externí odkaz:
https://doaj.org/article/46dc4df6f9e744ea8b4f59ab770794ab
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Primary splenic angiosarcoma (PSA) is a rare malignancy with poor prognosis. At present, little study is available on immunotherapy in PSA. Here, we report a case of a patient with metastatic PSA who was treated with programmed death-1 (PD-1) inhibit
Externí odkaz:
https://doaj.org/article/89bad85f23894f3caaddab285f4d9289
Autor:
Dejian Li, Kai Zhao, Ziwen Zhao, Bo Jiang, Xianxu Gong, Yan Zhang, Yingqi Guo, Han Xiao, Ye Wang, Hui Liu, Chengqing Yi, Wenguang Gu
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Background: Malignant fibrous histiocytoma (MFH) is a common type of soft tissue sarcoma and a serious threat to human health. MFH often relapses locally after the curettage is related to the residual cancer stem cells (CSCs). Currently, the dysregul
Externí odkaz:
https://doaj.org/article/fa0aa6348ad84d44b779a74b05ee06eb
Autor:
Weilong Zhong, Wendong Yang, Yuan Qin, Wenguang Gu, Yinyin Xue, Yuanhao Tang, Hengwei Xu, Hongzhi Wang, Chao Zhang, Changhua Wang, Bo Sun, Yanrong Liu, Huijuan Liu, Honggang Zhou, Shuang Chen, Tao Sun, Cheng Yang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-14 (2019)
Abstract Background Anti-angiogenic therapies demonstrate anti-tumor effects by decreasing blood supply to tumors and inhibiting tumor growth. However, anti-angiogenic therapy may leads to changes in tumor microenvironment and increased invasiveness
Externí odkaz:
https://doaj.org/article/816215b49c07481db2c694f4dda50aff
Autor:
Wenguang Gu, Tao Zhang, Junsheng Gao, Yi Wang, Dejian Li, Ziwen Zhao, Bo Jiang, Zhiwei Dong, Hui Liu
Publikováno v:
Drug Delivery, Vol 26, Iss 1, Pp 918-927 (2019)
Protein-based nanocarriers with inherent biocompatibility have been widely served as building blocks to construct versatile therapeutic nanoplatforms. Herein, bovine serum albumin-iridium oxide nanoparticles (denoted BSA-IrO2 NPs) are successfully sy
Externí odkaz:
https://doaj.org/article/15cd6bb4b3534ee9a334856a9eac21ad
Autor:
Xiaonan, Wu, Jun, Zhao, Ling, Yang, Xin, Nie, Zheng, Wang, Ping, Zhang, Chao, Li, Xueqing, Hu, Min, Tang, Yuting, Yi, Xinhua, Du, Xuefeng, Xia, Yanfang, Guan, Zicheng, Yu, Wenguang, Gu, Xiangming, Quan, Lin, Li, Hong, Shi
Publikováno v:
Journal of Cancer. 13:1565-1572
Autor:
Kewei Wang, Huan Wang, Kaituo Gao, Zhiguo Chen, Wei Wang, Wenguang Gu, Xing Lei, Hao Jin, Wenbo Wang
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-14 (2021)
Cancer Cell International
Cancer Cell International
Background Osteosarcoma (OS) is a common malignant bone tumor with poor prognosis. We previously reviewed that CD146 is correlated with multiple cancer progression, while its impact on OS is currently not systematically studied. Methods MG63 was tran
Publikováno v:
Thin-Walled Structures. 179:109667
Autor:
Zhiguo Chen, Huan Wang, Kaituo Gao, Wei Wang, Xing Lei, Hao Jin, Kewei Wang, Wenguang Gu, Wenbo Wang
Background: Osteosarcoma (OS) is a common malignant bone tumor with poor prognosis. We previously reviewed that CD146 is correlated with multiple cancer progression, while its impact on OS is currently not systematically studied. Methods: we transfec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8d1dd26ca5143f5994da16395061fb2
https://doi.org/10.21203/rs.3.rs-328507/v1
https://doi.org/10.21203/rs.3.rs-328507/v1
Autor:
Yuting Yi, Jun Zhao, Wenguang Gu, Xue Yang, Zhen Liang, Minglei Zhuo, Xiaohan Chen, Chang Liu, Zicheng Yu, Yi Huang, Xiaoling Zeng, Jia Zhong, Nan Wu
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 145
Objectives Many MET rearrangements have been identified in various tumor types. However, the frequencies and characteristics of MET rearrangements are not well defined in non-small-cell lung cancer (NSCLC). We sought to illustrate the distribution of